Treatments

Treatment-Resistant AnxietyWhen First Treatments Don’t Work

Evidence-based care from an MD/PhD specialist · Serving SC & NY by telehealth

Published: October 4, 2026Read: 8 minCategory: Treatments
Quick answerTreatment-resistant anxiety means an anxiety disorder that hasn't improved enough after first-line treatment, such as an SSRI or CBT. It's common: trials often show response rates of 50% to 60% and remission rates of only 25% to 35%. Next steps include confirming the diagnosis, optimizing or switching medication, adding structured CBT, and treating co-occurring conditions.

You’ve tried a medication, maybe two. Perhaps you’ve done some therapy. The anxiety has eased a little, or not at all. It’s easy to conclude that nothing will work. But treatment-resistant anxiety is common, and there are well-studied next steps. This guide explains what treatment-resistant anxiety means, how common it is, what to check, and what options can help when first treatments fall short.

The first step is a careful review of what’s been tried and whether anything else is keeping anxiety going.

What Is Treatment-Resistant Anxiety?

Psychologist talking with a young man during a therapy session
Adding structured therapy can help even when medication hasn’t been enough.

Treatment-resistant anxiety generally means an anxiety disorder that hasn’t responded adequately to at least one or two first-line treatments, such as an SSRI or SNRI at an adequate dose and duration, or a course of cognitive behavioral therapy. Unlike depression, there’s no single agreed definition, which a review in FOCUS notes is one challenge in studying it.

It’s common. The same review estimated that perhaps 50% to 60% of people with anxiety disorders remain symptomatic despite first-line treatments.

Treatment-resistant anxiety at a glance
QuestionWhat it means
DefinitionInadequate response to one or two first-line treatments
How commonPerhaps 50%–60% remain symptomatic after first-line treatment
Typical trial resultsResponse 50%–60%, remission 25%–35%
Next stepsReview diagnosis, add CBT, switch or add medication

Anxiety Remission: How Often First Treatments Work

Anxiety remission, minimal or no symptoms, is reached less often than many people expect. As summarized in a study reprinted in FOCUS, trials of first-line anxiety treatments commonly show response rates of 50% to 60% and remission rates of only 25% to 35%, and relapse after remission is estimated at 10% to 15% at one year and 25% to 45% at five years, depending on the disorder.

That means many people who feel stuck are experiencing something typical, not a personal failure. Individual medications can do better in some trials; for example, a Psychiatric Times review described a trial in which 36% of people with GAD taking escitalopram reached remission compared with 16% on placebo.

What the research shows
Remission in GAD: escitalopram vs placebo

Share reaching remission in a trial of escitalopram for generalized anxiety disorder.

Source: Davidson et al., as described in Psychiatric Times.

Anxiety disorders are also different from one another, and treatment that fits one may not fit another. Panic disorder, social anxiety, GAD, OCD, and PTSD each have specific therapies with strong evidence, so the exact diagnosis shapes what comes next.

Anxiety that hasn't responded yet isn't anxiety that can't respond. It usually means the plan needs to change.

Anxiety Not Improving on Medication: What to Check

When anxiety is not improving on medication, it’s worth checking whether the dose and duration were adequate, whether doses were taken consistently, whether the diagnosis is right, and whether other factors, such as depression, ADHD, substance use, caffeine, sleep problems, or thyroid issues, are keeping anxiety going.

  • Adequate trial: the right dose for long enough, often 8 to 12 weeks.
  • Diagnosis: panic, OCD, PTSD, or bipolar features may need different approaches.
  • Co-occurring conditions: depression, ADHD, and sleep problems.
  • Substances: alcohol, cannabis, and caffeine can worsen anxiety.
  • Medical causes: thyroid problems and some medications.

Our guides to alcohol and anxiety and anxiety and insomnia explain some of these factors.

Anxiety still not better after treatment?

A fresh, careful review can help. By telehealth across South Carolina and New York.

Schedule an Evaluation →

CBT for Medication-Resistant Anxiety

CBT for medication-resistant anxiety can help even when medication hasn’t. In the CALM study, among primary care patients whose anxiety hadn’t responded to adequate medication, those who received collaborative-care CBT had about 58% response and 46% remission during the study, with clearly better outcomes than usual care at 6, 12, and 18 months.

When medication isn’t enough
CBT outcomes in medication-resistant anxiety

Share of medication-resistant primary care patients who responded and remitted with collaborative-care CBT.

Source: CALM study, Depression and Anxiety, 2016 (reprinted in FOCUS).

Structured CBT for a specific anxiety disorder, such as exposure for panic or social anxiety, or exposure and response prevention for OCD, is often more effective than general talk therapy. Our guides to panic disorder and social anxiety describe targeted approaches.

25%–35%
Typical remission rates in first-line anxiety trials
58%
Of medication-resistant patients responded to CBT in CALM
50%–60%
May remain symptomatic after first-line treatment
Sources: CALM study (FOCUS); FOCUS review of treatment-resistant anxiety.

Switching Anxiety Medication and Other Options

Switching anxiety medication is a common next step, often from one SSRI to another SSRI, to an SNRI, or occasionally to other classes, and a psychiatrist may also consider adding a medication such as buspirone or others depending on the diagnosis. The FOCUS review describes cross-tapering to another SSRI or an SNRI as a common, reasonable strategy.

  1. Review past trials. Confirm doses, duration, and adherence for each.
  2. Confirm the diagnosis. Look for panic, OCD, PTSD, depression, or ADHD.
  3. Address contributors. Sleep, substances, caffeine, and medical issues.
  4. Add targeted CBT. Use therapy designed for the specific anxiety disorder.
  5. Adjust medication. Switch or add, one change at a time.

Changes are made one at a time so their effects are clear. Benzodiazepines may help short term in some cases but carry dependence risks. Our guides to anxiety medication options, buspirone, and venlafaxine explain choices.

The problem

Anxiety that hasn’t budged

Medications or therapy tried, and anxiety still running your days.

The approach

A careful second look

A review of diagnosis, contributors, and what’s been tried, then a new plan.

The outcome

Real progress

Targeted therapy and medication changes that move you toward remission.

Portrait of Dr. Gabriella Farkas, MD PhD
Dr. Gabriella Farkas, MD PhD
Meet your psychiatrist

Dr. Gabriella Farkas, MD PhD

Board-certified adult psychiatrist with a PhD in neuroscience who specializes in hard-to-treat conditions. Dr. Farkas reviews every past trial before building a new anxiety plan.

About Dr. Farkas →

When to Get a Fresh Look

Get a fresh look at treatment if anxiety hasn’t improved after one or two adequate trials, if it’s interfering with work or relationships, or if you’re relying more on alcohol or as-needed medication to cope. A second opinion can uncover a missed diagnosis or a new approach.

A comprehensive psychiatric evaluation can review your history and build a new plan. Our guide to second opinions explains when one helps. If you’re in crisis, call or text 988 in the US.

Bringing a list of every medication tried, doses, how long, and what happened is one of the most useful things you can do for that visit.

Key Terms

Treatment-resistant anxiety
An anxiety disorder that hasn’t responded adequately to first-line treatment.
Adequate trial
A medication taken at a therapeutic dose for long enough to judge its effect.
Collaborative care
A model where primary care, mental health specialists, and care managers work together.
Cross-taper
Gradually lowering one medication while raising another.

Common Questions About Treatment-Resistant Anxiety

What is treatment-resistant anxiety?

Treatment-resistant anxiety generally means an anxiety disorder that hasn't improved enough after one or two first-line treatments, such as an SSRI or SNRI at an adequate dose and duration, or a course of CBT. There's no single definition. It's common. Next steps exist. A careful review is the place to start.

How common is treatment-resistant anxiety?

Treatment-resistant anxiety is common; reviews suggest perhaps 50% to 60% of people remain symptomatic after first-line treatment, and trials often show remission rates of only 25% to 35%. It's not a personal failure. Many people improve with next steps. Options continue. Persistence helps. Your psychiatrist can guide you. Progress is possible.

Why isn't my anxiety improving on medication?

Anxiety may not improve on medication because the dose or duration wasn't adequate, doses were missed, the diagnosis needs refining, or other factors such as depression, ADHD, sleep problems, substances, or thyroid issues are involved. A careful review helps. Each factor can be addressed. Changes are made one at a time. Your psychiatrist can guide you.

Can CBT help if medication didn't work?

Yes, CBT can help when medication hasn't; in the CALM study, about 58% of patients with medication-resistant anxiety responded and 46% remitted with collaborative-care CBT. Targeted therapy matters. It can be combined with medication. Skills last. Ask about specialized CBT. Your psychiatrist can guide you. Progress is possible. Tracking helps. Ask questions anytime.

Should I switch anxiety medications?

Switching anxiety medications is a common next step, often to another SSRI or to an SNRI, and it should be done with your psychiatrist using a planned taper or cross-taper. Adding a medication is another option. Changes happen one at a time. Side effects are monitored. Don't stop suddenly. Your psychiatrist can guide you.

Are benzodiazepines the answer for treatment-resistant anxiety?

Benzodiazepines may help some people short term, but they carry an FDA boxed warning about dependence and withdrawal, so they're usually not a long-term solution for treatment-resistant anxiety. Other options are often preferred. Risks rise with alcohol or opioids. Discuss carefully. Your psychiatrist can advise. Your psychiatrist can guide you. Progress is possible.

Can I get a treatment review by telehealth?

Yes, Dr. Farkas reviews treatment-resistant anxiety by secure telehealth for adults in South Carolina and New York, looking at past trials, diagnosis, and contributors before building a new plan. Bring your medication history. You'll need a private space. Therapy referrals can be arranged. Follow-ups use the same platform. Your psychiatrist can guide you.

SummaryTreatment-resistant anxiety is common, with first-line trials often showing only 25% to 35% remission. A careful review of diagnosis, past trials, and contributors, then targeted CBT and thoughtful medication changes, helps many people move from partial relief toward remission.

Anxiety that hasn’t responded yet can still respond.

A careful, evidence-based second look.

Book Your Evaluation →

Sources

  1. FOCUS (American Psychiatric Association). “CBT for medication-resistant anxiety in primary care: CALM study (reprinted from Depression and Anxiety, 2016;33:1099–1106).” FOCUS. https://focus.psychiatryonline.org/doi/10.1176/appi.focus.15204
  2. FOCUS (American Psychiatric Association). “Advances in the management of treatment-resistant anxiety disorders.” FOCUS, 2010;8(4). https://focus.psychiatryonline.org/doi/10.1176/foc.8.4.foc501
  3. Psychiatric Times. “Pharmacological strategies for generalized anxiety disorder.” Psychiatric Times. https://www.psychiatrictimes.com/view/pharmacological-strategies-generalized-anxiety-disorder

Educational content only. This article does not constitute medical advice and does not establish a doctor-patient relationship. If you are in crisis, call or text 988 (Suicide & Crisis Lifeline) or call 911. Treatment decisions should be made with a qualified clinician familiar with your circumstances. Last reviewed: October 2026.

Vital Voice Online

Schedule a Consultation

Fill out the form below and we'll get back to you within 24 hours.

Request Sent!

We've received your request and will be in touch within 24 hours.

Something went wrong